VIRUS COVID-19 Registry

VIRUS
Viral Infection and Respiratory Illness Universal Study:
COVID-19 Registry and Validation of Critical Care Data Dictionary (C2D2)

Please review the VIRUS participating sites before enrolling in the study, to see if your site is already enrolled. Click on this link.

To participate, please complete this intake form.

VIRUS FAQs

What is the VIRUS Study?

VIRUS is a prospective, cross-sectional, observational study and registry of all eligible adult and pediatric patients who are admitted to a hospital. There is no intervention or patient interaction. Only de-identified data will be used for analysis.

Inclusion Criteria:

COVID-19 polymerase chain reaction (PCR) positive within 7 days
Pending COVID-19 PCR testing
High clinical suspicion for COVID-19

What are the primary aims of the VIRUS study?

Aim 1: Create a real time COVID-19 registry of current ICU and hospital care patterns to allow evaluation of safety and observational effectiveness of COVID-19 practices

Aim 2: Determine practice variations across different hospitals

Hypothesis: The registry will be essential for near-real time observational comparative effectiveness studies to learn effective treatment strategies and/or provide meaningful hypotheses for clinical trials.

VIRUS Investigators

Discovery, the Critical Care Research Network, is leading the efforts for this global COVID-19 registry.

Principal Investigator:
Rahul Kashyap, MBBS, MBA (Mayo Clinic)

Co-Principal Investigators:
Allen J. Walkey, MD, MSc (Boston University)
Vishakha Kumar, MD, MBA (Discovery, Society of Critical Care Medicine)

Institutional Review Board - Waiver of Consent

A waiver of informed consent for data collection is being requested for this study from participating sites. No patients will be contacted, but clinicians participating in the study will be surveyed for feedback and satisfaction.

For any questions, contact Vishakha Kumar.